speb/financial-data huggingface dataset:
Financial ratios for MTA.V — annual report dated 2024-12-31
Total revenue: 4113286.7132867137
Gross profit: 2358741.2587412586
Operating income: -3130069.9300699304
Net income: -3829370.6293706293
Capital expenditures: 1537762.237762238
Operating cash flow: -1799300.6993006994
Depreciation & amortization: 1754545.4545454546
Net tangible assets: 176242657.34265736
Owner earnings: -3612587.4125874126
Return on net tangible assets (%): -2.049780380673499
Buffett classification: The Gruesome
Stock price: 2.5314685314685317
Shares outstanding: 93442762
Book value: 176242657.34265736
P/B ratio: 1.3421688884127494
Market cap (USD): 236547411.4965035
Debt to equity: 0.05036365151352831
Current ratio: 0.9333621497010302
Quick ratio: 0.9333621497010302
Interest coverage ratio: -2.2640364188163886
COGS to revenue (%): 42.655559333560014
SG&A to revenue (%): 133.44100646038763
Free cash flow (dilution-adjusted): -5177622.377622378
Buyback yield (%): 0
Retained earnings: -48141258.74125874
Receivables turnover: 2.337837837837838
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7566994772288416
FCF margin (%): -125.87555253315199
Revenue growth (%): 18.161881643927362
Rule of 40 score: -107.71367088922463
Financial ratios for MTA.V — quarterly report dated 2025-03-31
Total revenue: 1203496.5034965035
Gross profit: 855944.055944056
Operating income: -154545.45454545456
Net income: -511188.8111888112
Capital expenditures: 0
Operating cash flow: 441258.7412587413
Depreciation & amortization: 347552.44755244756
Net tangible assets: 176842657.34265736
Owner earnings: -163636.36363636365
Return on net tangible assets (%): -0.0925321786582834
Buffett classification: The Gruesome
Stock price: 2.909090909090909
Shares outstanding: 93442762
Book value: 176842657.34265736
P/B ratio: 1.5371488618146587
Market cap (USD): 271833489.45454544
Debt to equity: 0.042335448919469325
Current ratio: 0.8648425167255507
Quick ratio: 0.8648425167255507
Interest coverage ratio: -0.49330357142857145
COGS to revenue (%): 28.87855897733876
SG&A to revenue (%): 83.96281231841952
Free cash flow (dilution-adjusted): 59440.559440559475
Buyback yield (%): 0
Retained earnings: -48652447.55244756
Receivables turnover: 0.9706711787930061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.08720666400969139
FCF margin (%): 4.938988959907034
Rule of 40 score: 4.938988959907034
Financial ratios for MTA.V — quarterly report dated 2025-06-30
Total revenue: 1967153.2846715327
Gross profit: 1559854.01459854
Operating income: 164233.57664233574
Net income: -1267153.2846715327
Capital expenditures: 0
Operating cash flow: 508759.1240875912
Depreciation & amortization: 407299.27007299266
Net tangible assets: 183937226.27737224
Owner earnings: -859854.01459854
Return on net tangible assets (%): -0.46747144773288246
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.8102189781021893
Shares outstanding: 93442762
Book value: 183937226.27737227
P/B ratio: 1.9356461568132572
Market cap (USD): 356037385.1386861
Debt to equity: 0.047703516750398814
Current ratio: 4.03931203931204
Quick ratio: 4.03931203931204
Interest coverage ratio: 0.4955947136563876
COGS to revenue (%): 20.705009276437846
SG&A to revenue (%): 70.94619666048237
Free cash flow (dilution-adjusted): -108029.19708029192
Buyback yield (%): 0
Retained earnings: -52050364.963503644
Receivables turnover: 0.9746835443037974
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.08504976356165729
FCF margin (%): -5.491651205936918
Revenue growth (%): 63.45317821500824
Rule of 40 score: 57.961527009071325
Financial ratios for MTA.V — quarterly report dated 2025-09-30
Total revenue: 2877697.841726619
Gross profit: 2405755.3956834534
Operating income: 1050359.712230216
Net income: 452517.9856115108
Capital expenditures: 0
Operating cash flow: 1418705.0359712231
Depreciation & amortization: 471942.4460431655
Net tangible assets: 182295683.4532374
Owner earnings: 924460.4316546763
Return on net tangible assets (%): 0.507121405259066
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.381294964028777
P/E ratio: 329.4265894038156
Shares outstanding: 93442762
Book value: 182295683.4532374
P/B ratio: 3.2709816013196997
Market cap (USD): 596285826.5755396
Debt to equity: 0.04774044855578928
Current ratio: 5.035619174434088
Quick ratio: 5.035619174434088
Effective tax rate (%): 37.28813559322033
Interest coverage ratio: 4.066852367688022
COGS to revenue (%): 16.400000000000002
SG&A to revenue (%): 47.099999999999994
Free cash flow (dilution-adjusted): 866187.0503597123
Buyback yield (%): 0
Retained earnings: -50848920.86330935
Receivables turnover: 1.1915400655347035
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5488432939619721
FCF margin (%): 30.100000000000005
Revenue growth (%): 46.28742275196542
Rule of 40 score: 76.38742275196543
Financial ratios for MTA.V — quarterly report dated 2025-12-31
Total revenue: 2425547.445255474
Gross profit: 2039416.0583941604
Operating income: -1115328.4671532847
Net income: -1754014.598540146
Capital expenditures: 1778832.116788321
Operating cash flow: 808759.1240875912
Depreciation & amortization: 386131.38686131383
Net tangible assets: 183761313.86861312
Owner earnings: -3146715.328467153
Return on net tangible assets (%): -1.7123927023709746
Buffett classification: The Gruesome
Stock price: 7.708029197080291
Shares outstanding: 93442762
Book value: 183761313.86861312
P/B ratio: 3.9195384631762087
Market cap (USD): 720259537.7518247
Debt to equity: 0.048364865562674525
Current ratio: 2.4067373674360573
Quick ratio: 2.4067373674360573
Interest coverage ratio: -4.340909090909091
COGS to revenue (%): 15.919349984953355
SG&A to revenue (%): 130.06319590731266
Free cash flow (dilution-adjusted): -1528467.1532846715
Buyback yield (%): 0
Retained earnings: -53345255.47445255
Receivables turnover: 0.7588490522950445
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.577794247770879
FCF margin (%): -63.015347577490225
Revenue growth (%): -15.712226277372277
Rule of 40 score: -78.7275738548625
Financial ratios for MTA.V — annual report dated 2025-12-31
Total revenue: 8568613.13868613
Gross profit: 6933576.642335766
Operating income: -46715.32846715328
Net income: -3095620.437956204
Capital expenditures: 1778832.116788321
Operating cash flow: 3217518.2481751824
Depreciation & amortization: 1635036.4963503648
Net tangible assets: 183761313.86861312
Owner earnings: -3239416.05839416
Return on net tangible assets (%): -1.7628389731204792
Buffett classification: The Gruesome
Stock price: 7.708029197080291
Shares outstanding: 93442762
Book value: 183761313.86861312
P/B ratio: 3.9195384631762087
Market cap (USD): 720259537.7518247
Debt to equity: 0.048364865562674525
Current ratio: 2.4067373674360573
Quick ratio: 2.4067373674360573
Interest coverage ratio: -0.03967761934283943
COGS to revenue (%): 19.08169350029815
SG&A to revenue (%): 81.46349774256751
Free cash flow (dilution-adjusted): -695620.4379562042
Buyback yield (%): 0
Retained earnings: -53345255.47445255
Receivables turnover: 2.6807490294587804
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.024200806189356185
FCF margin (%): -8.118238350796489
Revenue growth (%): 108.31548433051962
Rule of 40 score: 100.19724597972314
Financial ratios for MTX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 71.45
Shares outstanding: 31008734
Market cap (USD): 2215574044.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTX — annual report dated 2022-12-31
Total revenue: 2125500000
Gross profit: 465000000
Operating income: 252500000
Net income: 126300000
Capital expenditures: 82300000
Operating cash flow: 105700000
Depreciation & amortization: 94200000
Net tangible assets: 422800000
Owner earnings: 138200000
Return on net tangible assets (%): 32.68684957426679
Capex to operating income (%): 32.5940594059406
Buffett classification: The Good
Stock price: 59.5
P/E ratio: 14.608231773555028
Shares outstanding: 31008734
Book value: 1613200000
P/B ratio: 1.1437017561368708
Market cap (USD): 1845019673
Debt to equity: 0.6585048351103397
Current ratio: 2.129924393155591
Quick ratio: 1.435933147632312
Effective tax rate (%): 20.485003190810467
Interest coverage ratio: 5.751708428246014
COGS to revenue (%): 78.12279463655611
R&D to revenue (%): 0.9597741707833451
SG&A to revenue (%): 9.202540578687369
Free cash flow (dilution-adjusted): 13000000
Buyback yield (%): 3.03519798837397
Retained earnings: 2284600000
Inventory turnover: 4.760607798165138
Receivables turnover: 5.2611386138613865
Capitalized R&D asset: 20400000
ROCI (R&D-adjusted, %): 9.114886620538467
FCF margin (%): 0.6116207951070336
Rule of 40 score: 0.6116207951070336
Financial ratios for MTX — annual report dated 2023-12-31
Total revenue: 2169900000
Gross profit: 507100000
Operating income: 279900000
Net income: 88300000
Capital expenditures: 93500000
Operating cash flow: 233600000
Depreciation & amortization: 95000000
Net tangible assets: 507400000
Owner earnings: 89800000
Return on net tangible assets (%): 17.698068584942845
Capex to operating income (%): 33.40478742408003
Buffett classification: The Good
Stock price: 70.18
P/E ratio: 24.645446796375992
Shares outstanding: 31008734
Book value: 1686700000
P/B ratio: 1.2902074773937275
Market cap (USD): 2176192952.1200004
Debt to equity: 0.6014703266733858
Current ratio: 2.4032363874917997
Quick ratio: 1.6916684889569211
Effective tax rate (%): 22.00557103064067
Interest coverage ratio: 4.72804054054054
COGS to revenue (%): 76.63025945896125
R&D to revenue (%): 0.9770035485506244
SG&A to revenue (%): 9.4935250472372
Free cash flow (dilution-adjusted): 128800000
Buyback yield (%): 0.6525156689882056
Retained earnings: 2360600000
Inventory turnover: 5.110018438844499
Receivables turnover: 5.436983212227512
Capitalized R&D asset: 34868000
ROCI (R&D-adjusted, %): 9.822737042924118
Rosenberg metric: 2.0637254901960786
FCF margin (%): 5.935757408175492
Revenue growth (%): 2.088920254057869
Rule of 40 score: 8.024677662233362
Financial ratios for MTX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 76.31
Shares outstanding: 31008734
Market cap (USD): 2366276491.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTX — annual report dated 2024-12-31
Total revenue: 2118500000
Gross profit: 547700000
Operating income: 315500000
Net income: 170900000
Capital expenditures: 89500000
Operating cash flow: 236400000
Depreciation & amortization: 94900000
Net tangible assets: 615100000
Owner earnings: 176300000
Return on net tangible assets (%): 28.662006177857258
Capex to operating income (%): 28.367670364500793
Buffett classification: The Good
Stock price: 75.41
P/E ratio: 13.682671918899942
Shares outstanding: 31008734
Book value: 1783200000
P/B ratio: 1.3113327898945715
Market cap (USD): 2338368630.94
Debt to equity: 0.5446388515029161
Current ratio: 2.843852149861705
Quick ratio: 1.9836560221272317
Effective tax rate (%): 26.565295169946335
Interest coverage ratio: 5.593971631205674
COGS to revenue (%): 74.14680198253481
R&D to revenue (%): 1.085673825820156
SG&A to revenue (%): 9.87491149398159
Free cash flow (dilution-adjusted): 135100000
Buyback yield (%): 2.7198449020603506
Retained earnings: 2514500000
Inventory turnover: 4.591639871382637
Receivables turnover: 5.499740394600208
Capitalized R&D asset: 43936000
ROCI (R&D-adjusted, %): 10.426068658331952
Rosenberg metric: 1.9150943396226414
FCF margin (%): 6.377153646447958
Revenue growth (%): -2.368772754504816
Rule of 40 score: 4.008380891943142
Financial ratios for MTX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 75.41
Shares outstanding: 31008734
Market cap (USD): 2338368630.94
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTX — quarterly report dated 2025-03-31
Total revenue: 491800000
Gross profit: 119600000
Operating income: 63200000
Net income: -143000000
Capital expenditures: 18300000
Operating cash flow: -4400000
Depreciation & amortization: 23500000
Net tangible assets: 467800000
Owner earnings: -137800000
Return on net tangible assets (%): -29.4570329200513
Capex to operating income (%): 28.955696202531644
Buffett classification: The Good
Stock price: 63
Shares outstanding: 31008734
Book value: 1634800000
P/B ratio: 1.1949781269880109
Market cap (USD): 1953550242
Debt to equity: 0.6033765598238316
Current ratio: 1.893982330388398
Quick ratio: 1.3063843973995666
Interest coverage ratio: 4.450704225352113
COGS to revenue (%): 75.68117120780805
R&D to revenue (%): 1.1793411956079707
SG&A to revenue (%): 10.288735258235054
Free cash flow (dilution-adjusted): -22700000
Buyback yield (%): 0.5886718320705467
Retained earnings: 2366900000
Inventory turnover: 1.055886524822695
Receivables turnover: 1.2116284799211627
Capitalized R&D asset: 5800000
ROCI (R&D-adjusted, %): 2.3891798178428507
FCF margin (%): -4.61569743798292
Rule of 40 score: -4.61569743798292
Financial ratios for MTX — quarterly report dated 2025-06-30
Total revenue: 528900000
Gross profit: 136900000
Operating income: 79000000
Net income: 46300000
Capital expenditures: 29100000
Operating cash flow: 62900000
Depreciation & amortization: 22000000
Net tangible assets: 523600000
Owner earnings: 39200000
Return on net tangible assets (%): 7.4866310160427805
Capex to operating income (%): 36.835443037974684
Buffett classification: The Good
Stock price: 54.68
P/E ratio: 9.15527848336933
Shares outstanding: 31008734
Book value: 1688000000
P/B ratio: 1.0044772364454977
Market cap (USD): 1695557575.12
Debt to equity: 0.5825236966824645
Current ratio: 1.9455872594558725
Quick ratio: 1.3490378234903782
Effective tax rate (%): 23.519458544839257
Interest coverage ratio: 5.8088235294117645
COGS to revenue (%): 74.11608999810927
R&D to revenue (%): 1.0777084515031197
SG&A to revenue (%): 9.869540555870675
Free cash flow (dilution-adjusted): 33800000
Buyback yield (%): 1.1205753363258875
Retained earnings: 2408900000
Inventory turnover: 1.0901001112347053
Receivables turnover: 1.2418408077013383
Capitalized R&D asset: 9586000
ROCI (R&D-adjusted, %): 2.825938716036026
Rosenberg metric: 2.9827586206896552
FCF margin (%): 6.390622045755341
Revenue growth (%): 7.5437169581130545
Rule of 40 score: 13.934339003868395
Financial ratios for MTX — quarterly report dated 2025-09-30
Total revenue: 532400000
Gross profit: 137000000
Operating income: 78400000
Net income: 44200000
Capital expenditures: 27300000
Operating cash flow: 70900000
Depreciation & amortization: 22400000
Net tangible assets: 547500000
Owner earnings: 39300000
Return on net tangible assets (%): 7.178082191780821
Capex to operating income (%): 34.82142857142857
Buffett classification: The Good
Stock price: 61.79
P/E ratio: 10.83727191097285
Shares outstanding: 31008734
Book value: 1709500000
P/B ratio: 1.1208129124656332
Market cap (USD): 1916029673.86
Debt to equity: 0.5719216145071658
Current ratio: 1.9836010143702452
Quick ratio: 1.3687235841081995
Effective tax rate (%): 23.851590106007066
Interest coverage ratio: 5.681159420289855
COGS to revenue (%): 74.26746806912095
R&D to revenue (%): 1.051840721262209
SG&A to revenue (%): 9.954921111945906
Free cash flow (dilution-adjusted): 43600000
Buyback yield (%): 0.8872513944813859
Retained earnings: 2448500000
Inventory turnover: 1.0871597470442673
Receivables turnover: 1.2878567972907595
Capitalized R&D asset: 11333000
ROCI (R&D-adjusted, %): 2.720041075051943
Rosenberg metric: 0.017543859649122806
FCF margin (%): 8.189331329827198
Revenue growth (%): 0.6617508035545472
Rule of 40 score: 8.851082133381745
Financial ratios for MTX — annual report dated 2025-12-31
Total revenue: 2072600000
Gross profit: 518000000
Operating income: 287100000
Net income: -14000000
Capital expenditures: 107100000
Operating cash flow: 193700000
Depreciation & amortization: 91200000
Net tangible assets: 588800000
Owner earnings: -29900000
Return on net tangible assets (%): -5.078125
Capex to operating income (%): 37.30407523510972
Buffett classification: The Good
Stock price: 60.75
Shares outstanding: 31008734
Book value: 1749700000
P/B ratio: 1.076630616962908
Market cap (USD): 1883780590.5
Debt to equity: 0.5496370806423958
Current ratio: 2.080662585523947
Quick ratio: 1.4501260352898813
Interest coverage ratio: 5.267889908256881
COGS to revenue (%): 75.00723728650004
R&D to revenue (%): 1.1048924056740326
SG&A to revenue (%): 10.035703946733571
Free cash flow (dilution-adjusted): 74700000
Buyback yield (%): 3.105457201067812
Retained earnings: 2481900000
Inventory turnover: 4.43917761279269
Receivables turnover: 5.1802049487628095
Capitalized R&D asset: 45306000
ROCI (R&D-adjusted, %): 9.720935147427236
Rosenberg metric: -1.291304347826087
FCF margin (%): 3.6041686770240275
Revenue growth (%): -2.1666273306584847
Rule of 40 score: 1.4375413463655429
Financial ratios for MTX — quarterly report dated 2025-12-31
Total revenue: 519500000
Gross profit: 124500000
Operating income: 66500000
Net income: 38500000
Capital expenditures: 32400000
Operating cash flow: 64300000
Depreciation & amortization: 23300000
Net tangible assets: 588800000
Owner earnings: 29400000
Return on net tangible assets (%): 4.993206521739131
Capex to operating income (%): 48.721804511278194
Buffett classification: The Good
Stock price: 60.75
P/E ratio: 12.232341496753246
Shares outstanding: 31008734
Book value: 1749700000
P/B ratio: 1.076630616962908
Market cap (USD): 1883780590.5
Debt to equity: 0.5496370806423958
Current ratio: 2.080662585523947
Quick ratio: 1.4501260352898813
Effective tax rate (%): 20.600858369098713
Interest coverage ratio: 5.155038759689923
COGS to revenue (%): 76.03464870067373
R&D to revenue (%): 1.1164581328200192
SG&A to revenue (%): 10.048123195380173
Free cash flow (dilution-adjusted): 31900000
Buyback yield (%): 0.5839321232777082
Retained earnings: 2481900000
Inventory turnover: 1.1279268989149058
Receivables turnover: 1.298425393651587
Capitalized R&D asset: 11433000
ROCI (R&D-adjusted, %): 2.276897388849972
Rosenberg metric: -2.232142857142857
FCF margin (%): 6.140519730510106
Revenue growth (%): -2.4229902329075883
Rule of 40 score: 3.7175294976025177
Financial ratios for PBM — annual report dated 2022-03-31
Total revenue: 0
Operating income: -1484757.864
Net income: -1486587.96
Capital expenditures: 0
Operating cash flow: -1117137.592
Net tangible assets: 1360201.208
Owner earnings: -1486587.96
Return on net tangible assets (%): -109.29176883954068
Buffett classification: The Gruesome
Stock price: 37537.5
Shares outstanding: 3814328
Book value: 1360201.208
P/B ratio: 105264.08626744873
Market cap (USD): 143180337300
Debt to equity: 0
Current ratio: 13.903927169472492
Quick ratio: 13.903927169472492
Free cash flow (dilution-adjusted): -1382792.24
Buyback yield (%): 0
Receivables turnover: 0
Capitalized R&D asset: 109789.66399999999
ROCI (R&D-adjusted, %): -96.02540951469712
Rule of 40 score: 0
Financial ratios for PBM — annual report dated 2023-03-31
Total revenue: 0
Operating income: -2396199.2592592593
Net income: -2375113.333333333
Capital expenditures: 0
Operating cash flow: -1179318.5185185184
Depreciation & amortization: 0
Net tangible assets: -148477.77777777778
Owner earnings: -2375113.333333333
Buffett classification: The Gruesome
Stock price: 39765
Shares outstanding: 3814328
Book value: -148477.77777777775
Market cap (USD): 151676752920
Debt to equity: 0
Current ratio: 0.8880633271904842
Quick ratio: 0.8880633271904842
Free cash flow (dilution-adjusted): -1343234.8148148148
Buyback yield (%): 0
Retained earnings: -4666626.666666666
Receivables turnover: 0
Capitalized R&D asset: 1265333.148954074
ROCI (R&D-adjusted, %): -146.68683222768036
Rule of 40 score: 0
Financial ratios for PBM — annual report dated 2024-03-31
Total revenue: 0
Operating income: -32114137.037037034
Net income: -37895590.370370366
Capital expenditures: 4242.222222222222
Operating cash flow: -2181751.8518518517
Depreciation & amortization: 177.77777777777777
Net tangible assets: -8127807.407407407
Owner earnings: -37899654.81481481
Buffett classification: The Gruesome
Stock price: 4275
Shares outstanding: 3814328
Book value: -8127807.407407407
Market cap (USD): 16306252200
Debt to equity: -0.9521850911457147
Current ratio: 0.09307724215199403
Quick ratio: 0.09307724215199403
Interest coverage ratio: -818.9132241551915
Free cash flow (dilution-adjusted): -2421462.2222222225
Buyback yield (%): 0
Retained earnings: -42562217.777777776
Receivables turnover: 0
Capitalized R&D asset: 1541825.1446755554
Rule of 40 score: 0
Financial ratios for PBM — quarterly report dated 2024-09-30
Total revenue: 0
Operating income: -857124.4444444444
Net income: 104794.8148148148
Capital expenditures: 0
Depreciation & amortization: 752.5925925925925
Net tangible assets: -929708.1481481481
Owner earnings: 105547.4074074074
Return on net tangible assets (%): -11.352746301905976
Buffett classification: The Gruesome
Stock price: 375
P/E ratio: 3412.318163183081
Shares outstanding: 3814328
Book value: -929708.1481481481
Market cap (USD): 1430373000
Debt to equity: -1.9925504300035217
Current ratio: 0.6393916212829945
Quick ratio: 0.6393916212829945
Interest coverage ratio: -311.47187079407803
Buyback yield (%): 0
Retained earnings: -40369140
Receivables turnover: 0
Capitalized R&D asset: 196760
Rule of 40 score: 0
Financial ratios for PBM — annual report dated 2025-03-31
Total revenue: 0
Operating income: -2561553.8461538465
Net income: 707545.4545454546
Capital expenditures: 6906.993006993007
Operating cash flow: -2611355.244755245
Depreciation & amortization: 2984.6153846153848
Net tangible assets: 4700702.097902098
Owner earnings: 703623.076923077
Return on net tangible assets (%): 14.96846773670471
Buffett classification: The Gruesome
Stock price: 30
P/E ratio: 161.7278992676346
Shares outstanding: 3814328
Book value: 4700702.097902098
P/B ratio: 24.343138028480794
Market cap (USD): 114429840
Debt to equity: 0
Current ratio: 11.037431481612341
Quick ratio: 11.037431481612341
Interest coverage ratio: -395.14800431499464
Free cash flow (dilution-adjusted): -2618262.237762238
Buyback yield (%): 0
Retained earnings: -39473569.23076923
Receivables turnover: 0
Capitalized R&D asset: 1106324.7364931365
ROCI (R&D-adjusted, %): -52.264180131880536
Rule of 40 score: 0
Financial ratios for PBM — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1083674.1007194244
Net income: -541909.3525179856
Capital expenditures: 0
Depreciation & amortization: 956.8345323741008
Net tangible assets: 8537465.4676259
Owner earnings: -540952.5179856116
Return on net tangible assets (%): -6.3362191043337805
Buffett classification: The Gruesome
Stock price: 20
Shares outstanding: 3814328
Book value: 8537465.467625901
P/B ratio: 8.93550437062134
Market cap (USD): 76286560
Debt to equity: 0
Current ratio: 8.090036985668053
Quick ratio: 8.090036985668053
Interest coverage ratio: -547.1511078823102
Buyback yield (%): 0
Retained earnings: -42043119.42446043
Receivables turnover: 0
Capitalized R&D asset: 388983.1568345324
ROCI (R&D-adjusted, %): -10.954242132572348
Rule of 40 score: 0
Financial ratios for PEB.AX — annual report dated 2022-03-31
Total revenue: 8003496.503496503
Gross profit: 8003496.503496503
Operating income: -15514685.314685315
Net income: -13837762.237762239
Capital expenditures: 498601.3986013986
Depreciation & amortization: 269930.06993006996
Net tangible assets: 75483916.08391608
Owner earnings: -14066433.566433568
Return on net tangible assets (%): -18.635007689314634
Buffett classification: The Gruesome
Stock price: 0.6390977443609022
Shares outstanding: 1241852687
Book value: 75787412.5874126
P/B ratio: 10.47225685630603
Market cap (USD): 793665251.0902255
Debt to equity: 0.01774378091090278
Current ratio: 18.433360858794384
Quick ratio: 18.267052023121387
COGS to revenue (%): 0
R&D to revenue (%): 21.59021406727829
SG&A to revenue (%): 202.12319790301444
Free cash flow (dilution-adjusted): -13061538.461538462
Buyback yield (%): 0.3405462440348095
Retained earnings: -132761538.46153846
Inventory turnover: 0
Receivables turnover: 2.852691924227318
Capitalized R&D asset: 1727972.0279720281
ROCI (R&D-adjusted, %): -18.387676293816064
FCF margin (%): -163.1979030144168
Rule of 40 score: -163.1979030144168
Financial ratios for PEB.AX — annual report dated 2023-03-31
Total revenue: 12337106.918238994
Gross profit: 12337106.918238994
Operating income: -21044025.1572327
Net income: -16959119.496855345
Capital expenditures: 1176100.6289308176
Depreciation & amortization: 416981.1320754717
Net tangible assets: 51403773.584905654
Owner earnings: -17718238.99371069
Return on net tangible assets (%): -34.46875152938873
Buffett classification: The Gruesome
Stock price: 0.2550335570469799
Shares outstanding: 1241852687
Book value: 52052201.25786163
P/B ratio: 6.084547827765983
Market cap (USD): 316714108.09395975
Debt to equity: 0.014765052015997489
Current ratio: 11.108799586509885
Quick ratio: 10.942499030882542
COGS to revenue (%): 0
R&D to revenue (%): 18.117862969004893
SG&A to revenue (%): 183.722471451876
Free cash flow (dilution-adjusted): -17914465.40880503
Buyback yield (%): 0
Retained earnings: -136361006.28930816
Inventory turnover: 0
Receivables turnover: 3.5710904787911892
Capitalized R&D asset: 3392961.3845274225
ROCI (R&D-adjusted, %): -36.13743071281013
Rosenberg metric: 2.5079169943673656
FCF margin (%): -145.20799347471453
Revenue growth (%): 54.146464771356584
Rule of 40 score: -91.06152870335794
Financial ratios for PEB.AX — annual report dated 2024-03-31
Total revenue: 14315568.86227545
Gross profit: 14315568.86227545
Operating income: -22025149.700598802
Net income: -17685628.74251497
Capital expenditures: 498203.5928143713
Depreciation & amortization: 1644311.377245509
Net tangible assets: 32138922.155688625
Owner earnings: -16539520.958083834
Return on net tangible assets (%): -51.46258756893726
Buffett classification: The Gruesome
Stock price: 0.05228758169934641
Shares outstanding: 1241852687
Book value: 32707784.431137722
P/B ratio: 1.9852605414706375
Market cap (USD): 64933473.83006536
Debt to equity: 0.07456702427593279
Current ratio: 6.9586389323073226
Quick ratio: 6.755681135024648
COGS to revenue (%): 0
R&D to revenue (%): 23.081105952231564
SG&A to revenue (%): 155.7911908646003
Free cash flow (dilution-adjusted): -16240718.562874252
Buyback yield (%): 0
Retained earnings: -147514371.25748503
Inventory turnover: 0
Receivables turnover: 5.088761174968072
Capitalized R&D asset: 5372019.870273965
ROCI (R&D-adjusted, %): -53.41648418199212
Rosenberg metric: 0.8851306952779867
FCF margin (%): -113.44794411678588
Revenue growth (%): 16.036676646706592
Rule of 40 score: -97.41126747007928
Financial ratios for PEB.AX — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 14459428.57142857
Buffett classification: The Gruesome
Stock price: 0.06918238993710692
Shares outstanding: 1241852687
Book value: 14905714.285714285
P/B ratio: 5.76385238504261
Market cap (USD): 85914336.83647798
Debt to equity: 0.11121334100057505
Current ratio: 3.1591677769806292
Quick ratio: 2.9944655119401458
Buyback yield (%): 0
Retained earnings: -157841142.85714287
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PEB.AX — annual report dated 2025-03-31
Total revenue: 12483428.57142857
Gross profit: 12483428.57142857
Operating income: -19487428.57142857
Net income: -17106285.714285713
Capital expenditures: 464571.4285714286
Depreciation & amortization: 1339428.5714285714
Net tangible assets: 14459428.57142857
Owner earnings: -16231428.57142857
Return on net tangible assets (%): -112.25497944988933
Buffett classification: The Gruesome
Stock price: 0.06918238993710692
Shares outstanding: 1241852687
Book value: 14905714.285714285
P/B ratio: 5.76385238504261
Market cap (USD): 85914336.83647798
Debt to equity: 0.11121334100057505
Current ratio: 3.1591677769806292
Quick ratio: 2.9944655119401458
COGS to revenue (%): 0
R&D to revenue (%): 66.97335896731667
SG&A to revenue (%): 106.78385059049714
Free cash flow (dilution-adjusted): -14864571.42857143
Buyback yield (%): 0
Retained earnings: -157841142.85714287
Inventory turnover: 0
Receivables turnover: 4.395573440643863
Capitalized R&D asset: 11312002.453314396
ROCI (R&D-adjusted, %): -58.5955108474959
Rosenberg metric: -0.5544897219489465
FCF margin (%): -119.07443010162044
Revenue growth (%): -12.798236021727055
Rule of 40 score: -131.8726661233475
Financial ratios for PHM7.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.40909090909091
Shares outstanding: 1669891235
Market cap (USD): 54119656843.40909
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHM7.DE — annual report dated 2022-12-31
Total revenue: 25096000000
Gross profit: 14246000000
Operating income: 11919000000
Net income: 5764000000
Capital expenditures: 205000000
Operating cash flow: 8256000000
Depreciation & amortization: 226000000
Net tangible assets: -21534000000
Owner earnings: 5785000000
Return on net tangible assets (%): -26.86449335933872
Capex to operating income (%): 1.7199429482339121
Buffett classification: The Great
Stock price: 33.776595744680854
P/E ratio: 9.785433931676069
Shares outstanding: 1669891235
Book value: -3923000000
Market cap (USD): 56403241182.180855
Debt to equity: -6.800917665052256
Current ratio: 0.8379758588672238
Quick ratio: 0.7010213556174559
Effective tax rate (%): 21.992150493977533
Interest coverage ratio: 10.566489361702128
COGS to revenue (%): 25.66942939113803
SG&A to revenue (%): 9.27239400701307
Free cash flow (dilution-adjusted): 8051000000
Buyback yield (%): 3.2356296584185693
Retained earnings: 29792000000
Inventory turnover: 5.459322033898305
Receivables turnover: 13.405982905982906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 42.06013127249629
FCF margin (%): 32.080809690787376
Rule of 40 score: 32.080809690787376
Financial ratios for PHM7.DE — annual report dated 2023-12-31
Total revenue: 24483000000
Gross profit: 14284000000
Operating income: 11547000000
Net income: 8130000000
Capital expenditures: 196000000
Operating cash flow: 9287000000
Depreciation & amortization: 272000000
Net tangible assets: -24017000000
Owner earnings: 8206000000
Return on net tangible assets (%): -34.16746471249532
Capex to operating income (%): 1.6974105828353685
Buffett classification: The Great
Stock price: 32.9
P/E ratio: 6.757616436838868
Shares outstanding: 1669891235
Book value: -3490000000
Market cap (USD): 54939421631.5
Debt to equity: -7.516618911174785
Current ratio: 0.493418146479371
Quick ratio: 0.38607650852548814
Effective tax rate (%): 25.60395314787701
Interest coverage ratio: 10.049608355091383
COGS to revenue (%): 25.397214393660906
SG&A to revenue (%): 11.179185557325491
Free cash flow (dilution-adjusted): 9091000000
Buyback yield (%): 1.820186617011347
Retained earnings: 31094000000
Inventory turnover: 5.117695473251029
Receivables turnover: 43.17989417989418
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 42.37275696304722
FCF margin (%): 37.13188743209574
Revenue growth (%): -2.4426203379024547
Rule of 40 score: 34.68926709419328
Financial ratios for PHM7.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.32222222222222
Shares outstanding: 1669891235
Market cap (USD): 74013290404.61111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHM7.DE — annual report dated 2024-12-31
Total revenue: 24018000000
Gross profit: 14367000000
Operating income: 11630000000
Net income: 11264000000
Capital expenditures: 142000000
Operating cash flow: 8753000000
Depreciation & amortization: 286000000
Net tangible assets: -22156000000
Owner earnings: 11408000000
Return on net tangible assets (%): -51.48943852680989
Capex to operating income (%): 1.2209802235597593
Buffett classification: The Great
Stock price: 46.395833333333336
P/E ratio: 6.8781956164643265
Shares outstanding: 1669891235
Book value: -2188000000
Market cap (USD): 77475995423.85417
Debt to equity: -11.392138939670932
Current ratio: 0.513950575105341
Quick ratio: 0.39095774968682384
Effective tax rate (%): 17.528188607409575
Interest coverage ratio: 10.346975088967971
COGS to revenue (%): 25.301856940627864
SG&A to revenue (%): 11.39561995170289
Free cash flow (dilution-adjusted): 8611000000
Buyback yield (%): 4.38845603906003
Retained earnings: 35516000000
Inventory turnover: 5.6268518518518515
Receivables turnover: 135.6949152542373
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 44.05970601606304
FCF margin (%): 35.852277458572736
Revenue growth (%): -1.8992770493812032
Rule of 40 score: 33.95300040919153
Financial ratios for PHM7.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.395833333333336
Shares outstanding: 1669891235
Market cap (USD): 77475995423.85417
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHM7.DE — quarterly report dated 2025-03-31
Total revenue: 5276000000
Gross profit: 3249000000
Operating income: 2661000000
Net income: 1077000000
Capital expenditures: 38000000
Operating cash flow: 2720000000
Depreciation & amortization: 71000000
Net tangible assets: -22518000000
Owner earnings: 1110000000
Return on net tangible assets (%): -4.9293898214761525
Capex to operating income (%): 1.4280345734686208
Buffett classification: The Great
Stock price: 54.42391304347826
P/E ratio: 21.096103845335772
Shares outstanding: 1669891235
Book value: -3460000000
Market cap (USD): 90882015365.70651
Debt to equity: -7.53150289017341
Current ratio: 0.5706241201313937
Quick ratio: 0.4709526044110746
Effective tax rate (%): 36.007130124777184
Interest coverage ratio: 10.15648854961832
COGS to revenue (%): 24.07126611068992
SG&A to revenue (%): 11.144806671721001
Free cash flow (dilution-adjusted): 2682000000
Buyback yield (%): 0.3587068340069108
Retained earnings: 34868000000
Inventory turnover: 1.1958568738229756
Receivables turnover: 20.449612403100776
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.599482174865564
FCF margin (%): 50.83396512509477
Rule of 40 score: 50.83396512509477
Financial ratios for PHM7.DE — quarterly report dated 2025-06-30
Total revenue: 6110000000
Gross profit: 3850000000
Operating income: 3231000000
Net income: 2378000000
Capital expenditures: 32000000
Operating cash flow: 205000000
Depreciation & amortization: 71000000
Net tangible assets: -22228000000
Owner earnings: 2417000000
Return on net tangible assets (%): -10.873672845060284
Capex to operating income (%): 0.9904054472299597
Buffett classification: The Great
Stock price: 54.305882352941175
P/E ratio: 26.24744340090236
Shares outstanding: 1669891235
Book value: -3206000000
Market cap (USD): 90684916950.11765
Debt to equity: -7.710542732376793
Current ratio: 0.3877430760164997
Quick ratio: 0.23806717737183264
Effective tax rate (%): 23.733162283515075
Interest coverage ratio: 11.74909090909091
COGS to revenue (%): 23.567921440261866
SG&A to revenue (%): 10.130932896890343
Free cash flow (dilution-adjusted): 173000000
Buyback yield (%): 0.30214506360602067
Retained earnings: 35525000000
Inventory turnover: 1.4173228346456692
Receivables turnover: 25.352697095435683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.648762918885062
FCF margin (%): 2.8314238952536828
Revenue growth (%): 15.807429871114481
Rule of 40 score: 18.638853766368165
Financial ratios for PHM7.DE — quarterly report dated 2025-09-30
Total revenue: 6076000000
Gross profit: 3812000000
Operating income: 3232000000
Net income: 2375000000
Capital expenditures: 54000000
Operating cash flow: 3094000000
Depreciation & amortization: 70000000
Net tangible assets: -21584000000
Owner earnings: 2391000000
Return on net tangible assets (%): -11.077650111193476
Capex to operating income (%): 1.670792079207921
Buffett classification: The Great
Stock price: 62.36470588235294
P/E ratio: 17.863169078266573
Shares outstanding: 1669891235
Book value: -2596000000
Market cap (USD): 104142275726.29413
Debt to equity: -9.900231124807396
Current ratio: 0.6177890417571807
Quick ratio: 0.48925899106927345
Effective tax rate (%): 22.76422764227642
Interest coverage ratio: 11.62589928057554
COGS to revenue (%): 23.68334430546412
SG&A to revenue (%): 9.545753785385122
Free cash flow (dilution-adjusted): 3040000000
Buyback yield (%): 0.10754518202997357
Retained earnings: 36115000000
Inventory turnover: 1.3511737089201878
Receivables turnover: 24.401606425702813
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.094903076117056
FCF margin (%): 50.032916392363404
Revenue growth (%): -0.5564648117839607
Rule of 40 score: 49.47645158057944
Financial ratios for PHM7.DE — quarterly report dated 2025-12-31
Total revenue: 5817000000
Gross profit: 3631000000
Operating income: 2911000000
Net income: 1117000000
Capital expenditures: 92000000
Operating cash flow: 3271000000
Depreciation & amortization: 54000000
Net tangible assets: -21165000000
Owner earnings: 1079000000
Return on net tangible assets (%): -5.098039215686274
Capex to operating income (%): 3.160425970456888
Buffett classification: The Great
Stock price: 55.6
P/E ratio: 13.364898901108392
Shares outstanding: 1669891235
Book value: -3452000000
Market cap (USD): 92845952666
Debt to equity: -7.447566628041715
Current ratio: 0.6480227223071882
Quick ratio: 0.5311339305221761
Effective tax rate (%): 26.17316589557171
Interest coverage ratio: 8.041436464088397
COGS to revenue (%): 24.89255630049854
SG&A to revenue (%): 12.377514182568335
Free cash flow (dilution-adjusted): 3179000000
Buyback yield (%): 0.3101912272213294
Retained earnings: 35452000000
Inventory turnover: 1.3532710280373832
Receivables turnover: 22.11787072243346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.255461470053744
FCF margin (%): 54.65016331442324
Revenue growth (%): -4.262672811059908
Rule of 40 score: 50.38749050336333
Financial ratios for PHM7.DE — annual report dated 2025-12-31
Total revenue: 23279000000
Gross profit: 14542000000
Operating income: 12035000000
Net income: 6947000000
Capital expenditures: 216000000
Operating cash flow: 9290000000
Depreciation & amortization: 266000000
Net tangible assets: -21165000000
Owner earnings: 6997000000
Return on net tangible assets (%): -33.05929600755965
Capex to operating income (%): 1.7947652679684254
Buffett classification: The Great
Stock price: 55.6
P/E ratio: 13.364898901108392
Shares outstanding: 1669891235
Book value: -3452000000
Market cap (USD): 92845952666
Debt to equity: -7.447566628041715
Current ratio: 0.6480227223071882
Quick ratio: 0.5311339305221761
Effective tax rate (%): 26.009159654915326
Interest coverage ratio: 10.225148683092609
COGS to revenue (%): 24.043129000386614
SG&A to revenue (%): 10.769362945143692
Free cash flow (dilution-adjusted): 9074000000
Buyback yield (%): 1.0770528722962827
Retained earnings: 35452000000
Inventory turnover: 5.230841121495327
Receivables turnover: 88.51330798479087
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 46.533658121640954
FCF margin (%): 38.97933760041239
Revenue growth (%): -3.076859022399867
Rule of 40 score: 35.90247857801253
Financial ratios for PYRAMID.NS — annual report dated 2024-03-31
Total revenue: 63847295.83882959
Gross profit: 15539105.40832234
Operating income: 4529955.630171483
Net income: 3518671.3035136107
Capital expenditures: 5216560.738697685
Operating cash flow: -456973.25818443456
Depreciation & amortization: 761841.9474757165
Net tangible assets: 26635627.773114283
Owner earnings: -936047.4877083581
Return on net tangible assets (%): -3.5142685416755763
Capex to operating income (%): 115.15699412049672
Buffett classification: The Gruesome
Stock price: 1.73260556621881
P/E ratio: 18.112959050367618
Shares outstanding: 36784800
Book value: 26645700.923372105
P/B ratio: 2.39188863582651
Market cap (USD): 63733549.23224568
Debt to equity: 0.08994390151148636
Current ratio: 2.5927283007882482
Quick ratio: 1.7704619759942675
Effective tax rate (%): 26.825059166506644
Interest coverage ratio: 22.319231905465287
COGS to revenue (%): 75.66207745501413
SG&A to revenue (%): 4.990922624246228
Free cash flow (dilution-adjusted): -5731454.610864612
Buyback yield (%): 0
Retained earnings: 12623300.155893993
Inventory turnover: 6.85681507933536
Receivables turnover: 5.360565271978744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.291550671603332
FCF margin (%): -8.976816536337864
Revenue growth (%): 9.19976868642721
Rule of 40 score: 0.22295215008934655
Financial ratios for PYRAMID.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 28122061.634018157
Buffett classification: The Gruesome
Stock price: 2.0346392737697085
Shares outstanding: 36784800
Book value: 28131258.958432868
P/B ratio: 2.66052077044807
Market cap (USD): 74843798.75776398
Debt to equity: 0.12596400482517245
Current ratio: 2.2028814258723437
Quick ratio: 1.4107464499515718
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PYRAMID.NS — quarterly report dated 2025-03-31
Total revenue: 20016518.587795183
Gross profit: 4836123.451017068
Operating income: 1083610.0070142623
Net income: 772492.4012158054
Capital expenditures: 0
Depreciation & amortization: 247708.67430441896
Net tangible assets: 29135620.762216505
Owner earnings: 1020201.0755202244
Return on net tangible assets (%): 3.501559427363346
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.5903839421169332
P/E ratio: 18.9328578319697
Shares outstanding: 36784800
Book value: 29147556.698620528
P/B ratio: 2.007096369650486
Market cap (USD): 58501955.233982965
Debt to equity: 0.22113423190798312
Current ratio: 2.337500767879302
Quick ratio: 1.588612042804664
Effective tax rate (%): 28.856278463840834
Interest coverage ratio: 13.865669409124905
COGS to revenue (%): 75.83933774594632
Buyback yield (%): 0
Retained earnings: 15477601.122281972
Inventory turnover: 2.1303353495979773
Receivables turnover: 1.4852156157239786
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2268216231721802
Rule of 40 score: 0
Financial ratios for PYRAMID.NS — annual report dated 2025-03-31
Total revenue: 69129705.40098199
Gross profit: 16587000.233808743
Operating income: 4094563.946691606
Net income: 3118143.5585690904
Capital expenditures: 8022129.997661912
Operating cash flow: 4092506.4297404718
Depreciation & amortization: 929261.1643675473
Net tangible assets: 29135620.762216505
Owner earnings: -3974725.274725274
Return on net tangible assets (%): -13.642150641525907
Capex to operating income (%): 195.92147300920203
Buffett classification: The Gruesome
Stock price: 1.5903839421169332
P/E ratio: 18.761790191863195
Shares outstanding: 36784800
Book value: 29147556.698620528
P/B ratio: 2.007096369650486
Market cap (USD): 58501955.233982965
Debt to equity: 0.22113423190798312
Current ratio: 2.337500767879302
Quick ratio: 1.588612042804664
Effective tax rate (%): 26.173783314742487
Interest coverage ratio: 12.98709629574697
COGS to revenue (%): 76.00597292061782
SG&A to revenue (%): 5.5840550753337155
Free cash flow (dilution-adjusted): -3937806.8739770865
Buyback yield (%): 0
Retained earnings: 15477601.122281972
Inventory turnover: 7.373561832389184
Receivables turnover: 5.129389385152121
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.19297292856377
FCF margin (%): -5.69625872284008
Revenue growth (%): 8.273505545930783
Rule of 40 score: 2.5772468230907037
Financial ratios for PYRAMID.NS — quarterly report dated 2025-06-30
Total revenue: 19168172.244324833
Gross profit: 4962286.449801077
Operating income: 1284589.2815352213
Net income: 925356.8921132694
Capital expenditures: 0
Depreciation & amortization: 276480.22466651065
Owner earnings: 1201837.11677978
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.1006318745611985
P/E ratio: 20.876086847662524
Shares outstanding: 36784800
Market cap (USD): 77271323.37935877
Effective tax rate (%): 25.169379258137774
Interest coverage ratio: 8.710012694382737
COGS to revenue (%): 74.11184339043973
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -4.238231237612011
Rule of 40 score: -4.238231237612011
Financial ratios for PYRAMID.NS — quarterly report dated 2025-09-30
Total revenue: 18130642.61555806
Gross profit: 4799199.549041714
Operating income: 1027057.4971815107
Net income: 693720.4058624577
Capital expenditures: 0
Depreciation & amortization: 317452.0856820744
Net tangible assets: 29475039.458850056
Owner earnings: 1011172.4915445321
Return on net tangible assets (%): 3.4306060657059496
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.7962795941375425
P/E ratio: 27.62862635229386
Shares outstanding: 36784800
Book value: 29490935.738444194
P/B ratio: 2.2405455764597764
Market cap (USD): 66075785.61443067
Debt to equity: 0.5366730304459819
Current ratio: 1.709143323802152
Quick ratio: 1.0738471073469698
Effective tax rate (%): 24.86170979204572
Interest coverage ratio: 5.730641001446814
COGS to revenue (%): 73.52989824572748
Buyback yield (%): 0
Inventory turnover: 1.3229470250168656
Receivables turnover: 1.3932909792356336
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6254328650014527
Revenue growth (%): -5.412772879657085
Rule of 40 score: -5.412772879657085
Financial ratios for PYRAMID.NS — quarterly report dated 2025-12-31
Total revenue: 17989439.679180127
Gross profit: 4803999.108833686
Operating income: 904043.6671493818
Net income: 527793.2494151721
Capital expenditures: 0
Depreciation & amortization: 349883.0344212989
Owner earnings: 877676.283836471
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.809401804611786
P/E ratio: 22.798975212742675
Shares outstanding: 36784800
Market cap (USD): 66558483.502283625
Effective tax rate (%): 25.16899361930634
Interest coverage ratio: 3.383050564842219
COGS to revenue (%): 73.29544891610193
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.7788082274412472
Rule of 40 score: -0.7788082274412472
Financial ratios for RCT — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -20656026.02739726
Buffett classification: The Gruesome
Stock price: 3
Shares outstanding: 59362026
Book value: -10964895.89041096
Market cap (USD): 178086078
Debt to equity: -1.1655566069251637
Current ratio: 0.2688234645660464
Quick ratio: 0.2688234645660464
Buyback yield (%): 0
Retained earnings: -239678464.38356164
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDAG — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -125457
Net income: 1833653
Capital expenditures: 0
Net tangible assets: 290460619
Owner earnings: 1833653
Return on net tangible assets (%): 0.631291431627776
Buffett classification: The Gruesome
Stock price: 10.26
P/E ratio: 41.965410031232736
Shares outstanding: 30000000
Book value: 290460619
P/B ratio: 1.0596961510985419
Market cap (USD): 307800000
Debt to equity: 0
Current ratio: 16.431522245128683
Quick ratio: 16.431522245128683
Buyback yield (%): 0
Retained earnings: -11495936
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.04138028361239014
Rule of 40 score: 0
Financial ratios for RDAG — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -71815
Net income: 3093694
Capital expenditures: 0
Net tangible assets: 293554313
Owner earnings: 3093694
Return on net tangible assets (%): 1.0538744835270057
Buffett classification: The Gruesome
Stock price: 10.21
P/E ratio: 24.75196318705082
Shares outstanding: 30000000
Book value: 293554313
P/B ratio: 1.0434184968013058
Market cap (USD): 306300000
Debt to equity: 0
Current ratio: 14.953158905544608
Quick ratio: 14.953158905544608
Buyback yield (%): 0
Retained earnings: -11556920
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.023447934401211113
Rule of 40 score: 0
Financial ratios for RDAG — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 296394212
Buffett classification: The Gruesome
Stock price: 10.13
Shares outstanding: 30000000
Book value: 296394212
P/B ratio: 1.025323665902086
Market cap (USD): 303900000
Debt to equity: 0
Current ratio: 13.88259089155247
Quick ratio: 13.88259089155247
Buyback yield (%): 0
Retained earnings: -11660355
Capitalized R&D asset: 0
Rule of 40 score: 0